1. |
Mancusi C, de Simone G, Brguljan Hitij J, et al. Management of patients with combined arterial hypertension and aortic valve stenosis: A consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J Cardiovasc Pharmacother, 2021, 7(3): 242-250.
|
2. |
Jin XY, Petrou M, Hu JT, et al. Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement. Front Med, 2021, 15(3): 416-437.
|
3. |
成泽怡, 郭应强. 经导管主动脉瓣置换术并发症的最新进展. 中国胸心血管外科临床杂志, 2019, 26(5): 494-498.
|
4. |
Grinberg T, Aviv Y, Vaturi M, et al. Noninvasive hemodynamic evaluation following TAVI for severe aortic stenosis. J Am Heart Assoc, 2023, 12(7): e028479.
|
5. |
Lindman BR, Goel K, Bermejo J, et al. Lower blood pressure after transcatheter or surgical aortic valve replacement is associated with increased mortality. J Am Heart Assoc, 2019, 8(21): e014020.
|
6. |
中华医学会心血管病学分会心血管影像学组, 北京医学会心血管病学会影像学组. 中国成人心脏瓣膜病超声心动图规范化检查专家共识. 中国循环杂志, 2021, 36(2): 109-125.
|
7. |
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 2018, 71(6): e13-e115.
|
8. |
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet, 2016, 387(10022): 957-967.
|
9. |
Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: A systematic review and network meta-analysis. JAMA Cardiol, 2017, 2(7): 775-781.
|
10. |
Inohara T, Manandhar P, Kosinski AS, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement. JAMA, 2018, 320(21): 2231-2241.
|
11. |
Ochiai T, Saito S, Yamanaka F, et al. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation. Heart, 2018, 104(8): 644-651.
|
12. |
Lindman BR, Goel K, Bermejo J, et al. Lower blood pressure after transcatheter or surgical aortic valve replacement is associated with increased mortality. J Am Heart Assoc, 2019, 8(21): e014020.
|
13. |
Endo N, Otsuki H, Domoto S, et al. Haemodynamic collapse immediately after transcatheter aortic valve implantation due to dynamic intraventricular gradient: A case report and review of the literature. Eur Heart J Case Rep, 2021, 5(2): ytaa565.
|
14. |
Dumonteil N, Vaccaro A, Despas F, et al. Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis. JACC Cardiovasc Interv, 2013, 6(11): 1195-1202.
|
15. |
Julario R, Mulia EPB, Rachmi DA, et al. Evaluation of heart rate variability using 24-hour Holter electrocardiography in hypertensive patients. J Arrhythm, 2020, 37(1): 157-164.
|
16. |
Tomiyama H, Shiina K. State of the art review: Brachial-ankle PWV. J Atheroscler Thromb, 2020, 27(7): 621-636.
|